Use of intravenous esmolol to predict efficacy of oral beta-adrenergic blocker therapy in patients with neurocardiogenic syncope
Authors:
- Vishnubhakta S. MurthyVMVishnubhakta S. Murthy
- Mohammad R. JazayeriMJMohammad R. Jazayeri
- Yue-Hua ShenYSYue-Hua Shen
- Paul J. TroupPTPaul J. Troup
- Boaz AvitallBABoaz Avitall
- Masood AkhtarMAMasood Akhtar
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Echocardiographic demonstration of decreased left ventricular dimensions and vigorous myocardial contraction during syncope induced by head-up tiltJACC, 1991
- Sequential catecholamine changes during upright tilt: Possible hormonal mechanisms responsible for pathogenesis of neurocardiogenic syncopeJACC, 1991
- TILTING TOWARDS A DIAGNOSIS IN RECURRENT UNEXPLAINED SYNCOPEThe Lancet, 1989
- Provocation of Bradycardia and Hypotension by Isoproterenol and Upright Posture in Patients with Unexplained SyncopeNew England Journal of Medicine, 1989
- Isoproterenol induction of vasodepressor-type reaction in vasodepressor-prone personsThe American Journal of Cardiology, 1989
- Esmolol: A titratable short-acting intravenous beta blocker for acute critical care settingsAmerican Heart Journal, 1987
- Role of cardiac vagal c-fibers in cardiovascular control1979
- Reflex control of the peripheral circulationProgress in Cardiovascular Diseases, 1976
- The Regulation of the Blood Distribution in ManActa Physiologica Scandinavica, 1952
- Depressor Reflexes from the HeartActa Physiologica Scandinavica, 1948